Trial Profile
Blood pressure lowering effect of combination therapy of angiotensin receptor blocker (ARB) and Ca antagonist in patients with high risk hypertension.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2009
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Olmesartan medoxomil/azelnidipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 27 Jul 2009 New trial record